THOMAS MCKINLEY - 14 May 2021 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Issuer symbol
TDOC
Transactions as of
14 May 2021
Net transactions value
$0
Form type
4
Filing time
18 May 2021, 16:17:18 UTC
Next filing
18 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1,049 +22% 5,879 14 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -1,049 -100% $0.000000* 0 14 May 2021 Common Stock 1,049 Direct F2, F3
transaction TDOC Restricted Stock Units Award $0 +1,638 $0.000000 1,638 17 May 2021 Common Stock 1,638 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F3 On May 28, 2020, the reporting person was granted 1,049 restricted stock units, vesting in full on May 17, 2021.
F4 The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders.